Efficacy and Treatment-Related Adverse Events of Romidepsin in PTCL Clinical Studies: A Systematic Review and Meta-Analysis

Frontiers in Medicine

Lijun Zhu¹  Xinle Han²  Suwen Lin²  Jian Hou³  Jun Du³  Chen Qiu⁴  Zoufang Huang⁵ 

[1] Binjiang College of Nanjing University of Information Engineering Information Management and System, Wuxi, China;Biomedical Research Institute, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, China;Department of Hematology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China;State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China;The First Affliated Hospital of Gannan Medical University, Ganzhou, China;

关键词: romidepsin;    PTCL;    efficiency;    adverse events;    systematic review;    meta-analysis;   

DOI  :  10.3389/fmed.2021.732727

来源: Frontiers

【 授权许可】

CC BY